trump and glp 1 The Great GLP-1 Reset: Trump's Medicare Deal Could Upend Telehealth's Most Profitable Subscription Big News: GLP-1 medicine prices

Our findings strongly suggest the answer is yes. Primes recent real-world study found 63% of high-potency GLP-1 (Wegovy or Zepbound) users who started treatment in Q1 2024 are still taking their medication after a year

From smaller portions to fewer take-out orders and an increase in protein-rich foods, weight-loss drugs are changing how Canadians eat

Promotes Beneficial Bacteria & Short-Chain Fatty Acids*

GLP 1 Drug Biosimilar Market segmentation by reference biologic in the GLP-1 drug biosimilar market includes semaglutide biosimilars, liraglutide biosimilars, exenatide biosimilars, and dulaglutide biosimilars.

SUPPORTS MIND-BODY CONNECTION & HABIT FORMATION: Designed to help reinforce healthy routines by supporting clearer hunger cues and more intentional eating patterns when used alongside a healthy lifestyle

Semaglutide has been shown to aid in weight loss by helping individuals feel fuller for longer and reducing cravings